Disease Progression Humans Lower Urinary Tract Symptoms/etiology Male Prostatic Hyperplasia/complications/*drug therapy Risk Factors Time Factors Treatment Outcome Benign prostatic hyperplasia Early treatment Luts Outcomes complications Pharmacological treatment Prostate Surgery

Adrenergic alpha-Antagonists Drug Therapy Combination Humans Lower Urinary Tract Symptoms Male Middle Aged Phosphodiesterase Inhibitors Prostatic Hyperplasia Randomized Controlled Trials as Topic

Humans Laser Therapy Male Patient Selection Preoperative Period Prostatic Hyperplasia/complications/physiopathology *Quality of Life Transurethral Resection of Prostate/*adverse effects/methods Treatment Outcome Urinary Bladder Underactive/etiology/*physiopathology *Urodynamics *muscle hypertonia *prostate *prostatic hyperplasia *urethra

Humans Laser Coagulation Laser Therapy Lasers Solid-State Male Non-Randomized Controlled Trials as Topic/statistics & numerical data Prostatic Hyperplasia/complications Quality of Life Randomized Controlled Trials as Topic/statistics & numerical data *Thulium Transurethral Resection of Prostate Treatment Outcome Ureteral Obstruction/etiology 2-micron Benign prostatic obstruction Plasmakinetic resection of prostate Safety and efficacy Thulium laser VapoResection of the prostate Thulium laser Transurethral resection of the prostate

Arteries Embolization Therapeutic/*adverse effects/methods/standards Humans Kallikreins/blood Lower Urinary Tract Symptoms/blood/etiology/*therapy Male Practice Guidelines as Topic Prostate/blood supply Prostate-Specific Antigen/blood Prostatic Hyperplasia/blood/complications/*therapy Quality of Life Treatment Outcome *arteries *embolization *investigational *prostatic hyperplasia *therapeutic *therapies *treatment outcome

Aged Causality Comorbidity Embolization Therapeutic/*statistics & numerical data Follow-Up Studies Humans Longitudinal Studies Lower Urinary Tract Symptoms/*epidemiology/*prevention & control Male Middle Aged Prostate/blood supply Prostatic Hyperplasia/diagnostic imaging/*epidemiology/*therapy Risk Factors Treatment Outcome

Aged Embolization Therapeutic Humans Lower Urinary Tract Symptoms/complications/therapy Male Prostate/blood supply/diagnostic imaging Prostatic Hyperplasia/complications/*therapy Treatment Outcome Bph Prostate artery embolisation Quality of life

Adrenergic alpha-Antagonists/administration & dosage/*therapeutic use Cholinergic Antagonists/administration & dosage Drug Therapy Combination Humans *Lower Urinary Tract Symptoms Male Prostatic Hyperplasia/*diagnosis/*drug therapy Publication Bias Quality of Life Treatment Outcome

5-alpha Reductase Inhibitors/*adverse effects Drug Therapy Combination Ejaculation/drug effects Erectile Dysfunction/*chemically induced/drug therapy Finasteride Humans Libido/*drug effects Male Middle Aged Prostatic Hyperplasia/*drug therapy Randomized Controlled Trials as Topic *5α-Reductase Inhibitors *Erectile Dysfunction *Meta-Analysis *Sexual Dysfunction

Erectile Dysfunction Holmium Humans *Laser Therapy Lasers Solid-State Length of Stay Male Prostatectomy Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Urethral Stricture Urinary Bladder Urinary Incontinence Urinary Retention benign prostatic hyperplasia bipolar transurethral plasmakinetic prostatectomy transurethral holmium laser enucleation of the prostate

*Arteries Embolization Therapeutic Humans Lower Urinary Tract Symptoms/etiology Male Prostate/*blood supply Prostatic Hyperplasia/complications/diagnosis/*therapy Quality of Life Risk Factors Time Factors Treatment Outcome

Humans Laser Therapy Male Prostate/radiation effects Prostatic Hyperplasia *Randomized Controlled Trials as Topic Transurethral Resection of Prostate Volatilization Benign prostate hyperplasia (BPH) Meta-analysis Photoselective vaporization of the prostate (PVP) Transurethral resection of the prostate (TURP)

Aged Blood Transfusion/statistics & numerical data Catheters Indwelling/statistics & numerical data Humans Laser Therapy Male Middle Aged Prospective Studies Prostatic Hyperplasia Randomized Controlled Trials as Topic Transurethral Resection of Prostate Treatment Outcome benign prostatic hyperplasia (BPH) prostate transurethral vaporesection transurethral resection of prostate (TURP)

Embolization Therapeutic Humans Lower Urinary Tract Symptoms/*therapy Male Prostate/*blood supply Prostatic Hyperplasia/physiopathology/*therapy benign prostatic hyperplasia lower urinary tract symptoms meta-analysis prostate artery embolization

*Arteries/diagnostic imaging Embolization Therapeutic Humans Kallikreins/blood Male Prostate/*blood supply Prostate-Specific Antigen/blood Prostatic Hyperplasia/diagnostic imaging/*therapy Quality of Life Time Factors Treatment Outcome

Botulinum Toxins Type A/administration & dosage Humans Injections Male Neuromuscular Agents/administration & dosage Prostatic Hyperplasia/*drug therapy Treatment Outcome Benign prostatic hyperplasia Botulinum toxin Meta-analysis Placebo

5α-Reductase inhibitors Benign prostatic hyperplasia Erectile dysfunction Finasteride Lower urinary tract symptoms Meta-analysis Permixon Phytotherapy Randomized controlled trial Serenoa repens Systematic review Tamsulosin α-Blockers

Humans Immune Checkpoint Inhibitors/therapeutic use *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/drug therapy Proportional Hazards Models Eastern Cooperative Oncology Group Immune checkpoint inhibitor Performance status Urothelial carcinoma

Humans *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/pathology *Urologic Neoplasms/drug therapy/pathology Antibodies Monoclonal/adverse effects

Humans *Gemcitabine Docetaxel/therapeutic use BCG Vaccine/adverse effects Adjuvants Immunologic *Urinary Bladder Neoplasms/therapy Administration Intravesical Neoplasm Invasiveness Neoplasm Recurrence Local